- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07472712
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
June 3, 2026 updated by: Virginia Commonwealth University
Integrating a Prescription Produce Program Within a Diabetes Prevention Program to Address Health Inequities Among Adults
Type 2 Diabetes remains a major chronic disease among adults in the United States.
A way to prevent Type 2 Diabetes is to engage in a diabetes prevention program.
In the diabetes prevention program, individuals at risk of Type 2 Diabetes meet with a health coach to learn effective ways to build health behaviors around diet and physical activity.
Individuals who participate in the diabetes prevention program are more likely to lose weight and eat a healthy diet.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The diabetes prevention program does not provide support for major factors influencing Type 2 diabetes, such as food insecurity or the challenge of accessing and eating healthy food to maintain optimal health.
Millions of adults who are at risk of Type diabetes face challenges such as food insecurity and access to healthcare, transportation, and housing.
A prescription produce program is a community-based initiative that supports an individual who may face food insecurity to access healthy fruits and vegetables and receive health advice and resources to manage their health, including referrals for health services, housing, and transportation.
This research examines whether or not a diabetes prevention program integrating a prescription produce program provides more benefits in preventing Type 2 diabetes compared to a regular diabetes prevention program.
Subjects in this study may lose weight, increase their knowledge of health, and provide additional services to manage their health.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ana Diallo
- Phone Number: (804) 852-0538
- Email: dialloa@vcu.edu
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Recruiting
- Virginia Commonwealth University
-
Contact:
- Ana Diallo
- Phone Number: 804-828-3432
- Email: dialloa@vcu.edu
-
Principal Investigator:
- Ana Diallo, PhD, MPH, BA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ≥age 18
- rationale: adolescents who are at-risk of T2DM may have unique needs that will not be addressed in this study
- Most recent BMI ≥ 25kg/m 2 and not pregnant
- rationale: elevated BMI is associated with higher risk of developing T2DM
- Elevated glucose as evidenced by one of the following criteria:
- Hemoglobin A1c 5.7-6.4% indicative of prediabetes within the last 36 months
- Fasting blood glucose 100-125mg/dl or 2-hour glucose 140-199mg/dl within the last six months
- Physician diagnosis of prediabetes (impaired fasting glucose, impaired glucose intolerance)
- These criteria indicate the presence of prediabetes and places individuals are risk of T2DM
- Speak, read, and understand English
- rationale: current version of PPP intervention (cooking classes) is available in English
- Have a working U.S.- based phone number
- rationale: participants must have a working phone number because they will receive automated text messages as reminders to receive session reminders; participants must have a working phone number in case adverse event monitoring contacts are required
- Able to attend study-related sessions at the Health Hub @ 25th over the year long study (i.e., weekly for 4 months, then monthly for 7 months)
- rationale: participants must be able to attend study activities at the community site in order to engage in the intervention and study related sessions.
Exclusion Criteria:
- Individuals with HbA1c or glucose levels above the indicated glucose ranges will be advised to see their physician and excluded from participation unless they receive physician consent to participate.
- Pregnant adults (>18 years old) will not be included in this current study because prediabetes (HbA1c levels between 5.7% - 6.4% within the last 36 months) during pregnancy presents unique physiological challenges that the study intervention does not address.
- Pregnancy status will be based on participants self-report. We will not provide any pregnancy tests prior to enrollment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prescription Produce Program (PPP) within a Diabetes Prevention Program (DPP)
The research intervention in this study is the DPP + Produce Prescription Plan (DPP+PPP).
Besides receiving the DPP, the intervention group participants will receive bags of fresh fruits and vegetables, attend four cooking demonstrations, and if there are positive screens for social needs, be referred to work with a community-based wellness program to access resources.
|
A 12-month lifestyle change program incorporating the latest evidence on self-efficacy, physical activity, and healthy diet.
The research intervention in this study is the DPP + Produce Prescription Plan (DPP+PPP).
Besides receiving the DPP, the intervention group participants will receive bags of fresh fruits and vegetables, attend four cooking demonstrations, and if there are positive screens for social needs, be referred to work with a community-based wellness program to access resources.
|
|
Placebo Comparator: Diabetes Prevention Program (DPP) only
All participants in this research study will participate in the Diabetes Prevention Program (DPP), which is a 12-month lifestyle change program incorporating the latest evidence on self-efficacy, physical activity, and healthy diet.
Additionally, all participants will be screened for social needs at regular timepoints and receive a list of available resources.
|
A 12-month lifestyle change program incorporating the latest evidence on self-efficacy, physical activity, and healthy diet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of recruitment rates
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Assess feasibility and acceptability by recording and measuring the recruitment rates.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of enrollment rates
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Assess feasibility and acceptability by recording and measuring the enrollment rates.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of attendance
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Assess feasibility and acceptability by recording and measuring the attendance rates.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of retention rates
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Assess feasibility and acceptability by recording and measuring the retention rates.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of blood glucose
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Blood glucose (hemoglobin A1c) will be recorded and measured to asses the blood glucose levels.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of weight
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Weight will be will be recorded and measured for assessment
|
Baseline, 16 weeks, 6 months, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of food security needs
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Using the Brief Social Needs evaluation to assess the participants food security needs using the Brief social needs including 2-item food security .
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of social needs
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Using the American Academic of Family Physician Social Needs Screening form to assess the participants social needs.
This assessment is a set of validated questions designed to help healthcare providers identify and address social determinants of health.
Underlined answers generally indicate a positive response for a social need.
For the Personal Safety section, a total numerical value greater than 10 indicates a positive screen.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of diet quality
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Using the Healthy Eating Index derived from DietID™,an assessment tool capturing dietary intake through innovative Diet Quality Photo Navigation (DQPN®) to assess the participants diet quality.
The Diet ID scoring system provides a diet quality score on a 1-10 scale.
A Diet ID score of 10 represents the highest quality (HEI 90-100), while a score of 1 represents the lowest.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of medication adherence
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Medication adherence will be recorded and measured for assessment
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of wellness goals set and met
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Wellness goals set and met will be recorded and measured for assessment
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of physical activity
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Physical activity will be recorded and measured for assessment using International Physical Activity Questionnaire (IPAQ) measures time spent sitting, light, moderate, and vigorous activity over a set period (e.g., past 7 days), increased activity time at a higher rate of activity will indicate increased physical activity.
|
Baseline, 16 weeks, 6 months, and 12 months
|
|
Assessment of Blood pressure
Time Frame: Baseline, 16 weeks, 6 months, and 12 months
|
Both systolic and diastolic blood pressure will be recorded and measured for assessment.
|
Baseline, 16 weeks, 6 months, and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ana Diallo, Virginia Commonwealth University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 26, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Study Registration Dates
First Submitted
March 5, 2026
First Submitted That Met QC Criteria
March 12, 2026
First Posted (Actual)
March 16, 2026
Study Record Updates
Last Update Posted (Actual)
June 5, 2026
Last Update Submitted That Met QC Criteria
June 3, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- HM300000239
- R01DK142965 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type2diabetes
-
Stanford UniversityNot yet recruiting
-
University of Erlangen-Nürnberg Medical SchoolBayerCompleted
-
Humanis Saglık Anonim SirketiCompleted
-
Gia Dinh People HospitalCompletedFasting | Gastric Emptying | Type2diabetes | Carbohydrate Loading | Enhanced Recovery After Surgery (ERAS)Vietnam
-
Atrogi ABCompleted
-
Chong Kun Dang PharmaceuticalCompletedType2DiabetesKorea, Republic of
-
Methodist Health SystemActive, not recruitingDiabetes | Type2diabetesUnited States
-
Universidade Nova de Lisboacruz vermelha hospitalRecruitingObesity | Bariatric Surgery Candidate | Metabolic Disease | Type2diabetesPortugal
-
Kennesaw State UniversityCompleted
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruiting
Clinical Trials on Diabetes Prevention Program (DPP)
-
The University of Texas Medical Branch, GalvestonWithdrawnHypertension | Prediabetic State | Overweight or Obesity | Gestational Weight Gain
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPreDiabetes | Type 2 Diabetes | Obesity, Childhood | Overweight and Obesity | Lifestyle, Healthy | Overweight, ChildhoodUnited States
-
University of Kansas Medical CenterKansas State University; National Institute of General Medical Sciences (NIGMS)CompletedWeight Loss | PreDiabetes | Lifestyle Risk ReductionUnited States
-
Indiana UniversityIndiana Clinical and Translational Sciences Institute; Regenstrief Institute... and other collaboratorsCompleted
-
University of Mississippi Medical CenterAmerican Medical Association; Mississippi State Department of HealthActive, not recruitingPreDiabetes | Prediabetic StateUnited States
-
University of UtahOhio State University; National Tongan American SocietyNot yet recruitingPhysical Inactivity
-
University of California, San FranciscoAmerican Heart AssociationCompletedCardiovascular Diseases | Obesity | Stress, Psychological | Weight Loss | Cardiovascular Risk Factor | Diabetes Prevention | Job Stress | Weight MaintenanceUnited States
-
University of California, San FranciscoAmerican Heart AssociationCompletedCardiovascular Diseases | Obesity | Stress, Psychological | Weight Loss | Cardiovascular Risk Factor | Diabetes Prevention | Job Stress | Weight MaintenanceUnited States
-
University of Missouri, Kansas CityChildren's Mercy Hospital Kansas City; University of Massachusetts, Amherst; University... and other collaboratorsRecruitingPreDiabetes | Overweight and ObesityUnited States
-
University of RochesterCompleted